Press "esc" to clear
Go to Advanced Search

Showing results

110 of 740
brennerwheeler.jpg

Article ID: 697460

By Sending Tests in the Mail, Researchers Boost Colorectal Cancer Screening

University of North Carolina Health Care System

Researchers with UNC Lineberger’s Carolina Cancer Screening Initiative, in collaboration with the Mecklenburg County Health Department in Charlotte, examined the impact of mailing tests to more than 2,100 people insured by Medicaid who were not up-to-date with colorectal cancer screening.

Released:
16-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
kombucha.jpg

Article ID: 697323

The Medical Minute: Kombucha Offers a Natural Way to Restore Body’s Microbiome

Penn State Health Milton S. Hershey Medical Center

Kombucha (pronounced kom-BOO-cha) can help restore the body’s natural microbiome and improve overall health, but it’s important to make informed choices about kombucha sources and consumption.

Released:
11-Jul-2018 4:40 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697277

Ludwig Cancer Research and Cancer Research Institute Launch Clinical Trial Combining Virotherapy and Immunotherapy to Treat Advanced Colorectal and Ovarian Cancers

Ludwig Cancer Research

Ludwig Cancer Research and the Cancer Research Institute (CRI) announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI® (durvalumab) for advanced ovarian and colorectal cancers.

Released:
11-Jul-2018 12:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697306

Ludwig Cancer Research and Cancer Research Institute Launch Clinical Trial Combining Virotherapy and Immunotherapy to Treat Advanced Colorectal and Ovarian Cancers

Cancer Research Institute and the Ludwig Cancer Research

A clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI® (durvalumab) for advanced ovarian and colorectal cancers has been initiated.

Released:
11-Jul-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
36033287690_6fd6a99b77_z.jpg

Article ID: 697132

Colorectal Cancer Advocates to Summit Quandary Peak Near Breckenridge, Colorado on Monday, July 16

Fight Colorectal Cancer

Over 80 colorectal cancer advocates will hike to Quandary Peak near Breckenridge, Colorado on Monday, July 16 to raise awareness.

Released:
9-Jul-2018 4:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
RS6302_anath_shalev_2011_2.jpg
  • Embargo expired:
    9-Jul-2018 11:00 AM EDT

Article ID: 697142

Path to Successful Diabetes Drug Trial Began with Simple Question

University of Alabama at Birmingham

• The ultimate goal of basic biomedical research is to better the lives of patients through prevention, control or cure of disease. • Crossing that gap between the lab and bedside is difficult to achieve. • One great need for better treatment is diabetes, a disorder that afflicts one of every 10 U.S. adults and doubles the risk of early death.

Released:
9-Jul-2018 11:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697017

Swallowed Sensor Sends Signal if You’re Sick

National Institute of Biomedical Imaging and Bioengineering

NIBIB-funded researchers at the Massachusetts Institute of Technology have created an ingestible sensor to non-invasively monitor indicators of disease in the stomach and intestines.

Released:
5-Jul-2018 9:25 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696998

Discovery of New Biomarker Could Provide Personalized Treatment Options for Bladder Cancer

Mount Sinai Health System

Mount Sinai researchers use data science and genomics to help determine best treatment options for specific types of disease

Released:
3-Jul-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
fatty-liver-disease-Intermountain.jpg

Article ID: 696967

Economic Burden of Fatty Liver Disease in U.S. is $32 Billion Annually, New Study Finds

Intermountain Medical Center

Nonalcoholic fatty liver disease, or NAFLD, which affects roughly 100 million Americans, costs the United States healthcare system $32 billion annually, according to a first-of-its-kind study by Intermountain Healthcare researchers on the economic impact of the disease.

Released:
3-Jul-2018 4:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696935

Mount Sinai Leaders Discuss the Future of Medicine at the 2018 Aspen Ideas Festival

Mount Sinai Health System

Experts provide on-site complimentary skin cancer and healthy heart screenings

Released:
2-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 740





Chat now!